Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-08-29

Clinical Trial Update: Study of Difluprednate in the Treatment of Uveitis [Phase 3]

View source ↗

Summary

Phase 3 study of difluprednate for uveitis has completed, according to the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIFLUPREDNATE (difluprednate)

Snippet

Sponsor: Sirion Therapeutics, Inc. | Conditions: Uveitis | Phase 3 | Status: COMPLETED